BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9791442)

  • 1. Tin-metalloporphyrins: an answer to neonatal jaundice?
    Steffensrud S
    Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
    Kappas A; Drummond GS; Henschke C; Valaes T
    Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
    Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
    J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
    [No Abstract]   [Full Text] [Related]  

  • 5. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloporphyrins for the treatment of neonatal jaundice.
    Dennery PA
    Curr Opin Pediatr; 2005 Apr; 17(2):167-9. PubMed ID: 15800405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
    Maisels MJ; Yang H
    J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of severe neonatal hyperbilirubinemia.
    Drummond GS; Kappas A
    Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
    Stevenson DK; Wong RJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Kappas A
    Pediatrics; 2004 Jan; 113(1 Pt 1):119-23. PubMed ID: 14702459
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative metalloporphyrins for the treatment of neonatal jaundice.
    Vreman HJ; Wong RJ; Stevenson DK
    J Perinatol; 2001 Dec; 21 Suppl 1():S108-13; discussion S125-7. PubMed ID: 11803430
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
    Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
    J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
    Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
    Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach to prevention of kernicterus.
    Cooke RW
    Lancet; 1999 May; 353(9167):1814-5. PubMed ID: 10359401
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity.
    Vreman HJ; Ekstrand BC; Stevenson DK
    Pediatr Res; 1993 Feb; 33(2):195-200. PubMed ID: 8433895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Alexander D
    Pediatrics; 2004 Jan; 113(1 Pt 1):135. PubMed ID: 14702465
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model.
    Drummond GS; Kappas A
    Science; 1982 Sep; 217(4566):1250-2. PubMed ID: 6896768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.